{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:51:15Z","timestamp":1754599875179},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Psoriatic arthritis (PsA) is associated with psoriasis, a chronic inflammatory skin disease. About 30% of patients with psoriasis develop PsA, and some of these patients are children and young adults. Because onset can be gradual, PsA signs and symptoms are easily attributed to other causes, especially in younger patients. This article discusses the assessment, pathophysiology, and diagnosis of PsA and informs nurses how best to support patients with PsA.<\/jats:p>","DOI":"10.1097\/01.nurse.0000718032.41238.db","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T23:23:01Z","timestamp":1601680981000},"page":"24-31","source":"Crossref","is-referenced-by-count":1,"title":["Supporting young adults with psoriatic arthritis"],"prefix":"10.1097","volume":"50","author":[{"given":"Christine M.","family":"Galante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1","key":"R1-20230930","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"R2-20230930","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","article-title":"Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis","volume":"48","author":"Scotti","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"R4-20230930","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J Autoimmun"},{"issue":"6","key":"R5-20230930","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","article-title":"Incidence of psoriasis in children: a population-based study","volume":"62","author":"Tollefson","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"R6-20230930","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R9-20230930","doi-asserted-by":"crossref","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis: review and update","volume":"214","author":"Perez-Chada","year":"2020","journal-title":"Clin Immunol"},{"issue":"4","key":"R10-20230930","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.clindermatol.2018.04.011","article-title":"Psoriatic arthritis and the dermatologist: an approach to screening and clinical evaluation","volume":"36","author":"Zhang","year":"2018","journal-title":"Clin Dermatol"},{"issue":"1","key":"R11-20230930","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","article-title":"Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey","volume":"3","author":"Kavanaugh","year":"2016","journal-title":"Rheumatol Ther"},{"issue":"10","key":"R12-20230930","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jdv.13150","article-title":"Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey","volume":"29","author":"van de Kerkhof","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"R13-20230930","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"R14-20230930","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12016-017-8630-7","article-title":"Clinical features of psoriatic arthritis: a comprehensive review of unmet clinical needs","volume":"55","author":"McArdle","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"R15-20230930","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/BOR.0b013e32835fd8d5","article-title":"Psoriatic arthritis and spondyloarthritis assessment and management update","volume":"25","author":"Mease","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"R16-20230930","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/bjd.12748","article-title":"Diagnosing and treating psoriatic arthritis: an update","volume":"170","author":"Boehncke","year":"2014","journal-title":"Br J Dermatol"},{"issue":"8","key":"R17-20230930","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R18-20230930","author":"Council","year":"2016","journal-title":"The Washington Manual of Dermatology Diagnostics"},{"issue":"3","key":"R19-20230930","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug-induced psoriasis: recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"R20-20230930","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/jid.2012.418","article-title":"Streptococcus induces circulating CLA(+) memory T-cell-dependent epidermal cell activation in psoriasis","volume":"133","author":"Ferran","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"2","key":"R21-20230930","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clindermatol.2019.01.011","article-title":"Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: a review","volume":"37","author":"Lewis","year":"2019","journal-title":"Clin Dermatol"},{"issue":"suppl 7","key":"R22-20230930","first-page":"S1","article-title":"Pathophysiology of psoriasis","volume":"79","author":"Mahajan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"R23-20230930","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ced.13014","article-title":"Psoriasis and metabolic syndrome in children: current data","volume":"42","author":"Pietrzak","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R24-20230930","article-title":"Kawasaki disease: complications","author":"Sundel","year":"2019"},{"key":"R25-20230930","article-title":"Koebner phenomenon. StatPearls [Internet]","author":"Sanchez","year":"2020"},{"issue":"5","key":"R26-20230930","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-013-2436-7","article-title":"Can traumatic injury trigger psoriatic arthritis? A review of the literature","volume":"33","author":"Hsieh","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"4","key":"R27-20230930","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138161282004140213123852","article-title":"Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review","volume":"20","author":"Brezinski","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"2","key":"R28-20230930","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"R29-20230930","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"R30-20230930","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"R31-20230930","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/amma-2014-0041","article-title":"Prevalence of metabolic syndrome in psoriatic arthritis and rheumatoid arthritis","volume":"60","author":"Craciun","year":"2014","journal-title":"Acta Med Marisiensis"},{"issue":"4","key":"R32-20230930","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5114\/ada.2018.77665","article-title":"The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor \u03b1 in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis","volume":"35","author":"Pirowska","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"issue":"5","key":"R33-20230930","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1468-3083.2008.03031.x","article-title":"Psoriasis associated with ulcerative colitis and Crohn's disease","volume":"23","author":"Cohen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R34-20230930","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41927-018-0034-7","article-title":"Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in PSOLAR registry","volume":"2","author":"Kavanaugh","year":"2018","journal-title":"BMC Rheumatol"},{"key":"R35-20230930","article-title":"Clinical manifestations and diagnosis of psoriatic arthritis","author":"Gladman","year":"2020"},{"issue":"1","key":"R36-20230930","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"R37-20230930","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-012-8302-6","article-title":"Psoriatic arthritis: a critical review","volume":"44","author":"Dhir","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R38-20230930","article-title":"Diagnosis and differential diagnosis of rheumatoid arthritis","author":"Venables","year":"2019"},{"issue":"1","key":"R39-20230930","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13075-020-2111-8","article-title":"A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations","volume":"22","author":"Sokolova","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"R40-20230930","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jdv.12257","article-title":"C-reactive protein in psoriasis: a review of the literature","volume":"28","author":"Beygi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R41-20230930","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3899\/jrheum.200128","article-title":"Development and validation of a sonographic enthesitis instrument in psoriatic arthritis: the GRAPPA diagnostic ultrasound enthesitis tool (DUET) project","volume":"96","author":"Eder","year":"2020","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"R42-20230930","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-017-1399-5","article-title":"The association between sonographic enthesitis and radiographic damage in psoriatic arthritis","volume":"19","author":"Polachek","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R43-20230930","article-title":"Differentiating rheumatoid and psoriatic arthritis: a systematic analysis of high-resolution magnetic resonance imaging features\u2014preliminary findings","author":"Abrar","journal-title":"Skeletal Radiol"},{"issue":"5","key":"R44-20230930","first-page":"24","article-title":"Imaging in peripheral and axial psoriatic arthritis: contributions to diagnosis, follow-up, prognosis and knowledge of pathogenesis","volume":"36","author":"Felbo","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"R46-20230930","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/acm.2019.0228","article-title":"Effect of yoga therapy on disease activity, inflammatory markers, and heart rate variability in patients with rheumatoid arthritis","volume":"26","author":"Ganesan","year":"2020","journal-title":"J Altern Complement Med"},{"issue":"6","key":"R47-20230930","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/acr2.11143","article-title":"Probiotic use and psoriatic arthritis disease activity","volume":"2","author":"Grinnell","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"11","key":"R48-20230930","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4103\/jfmpc.jfmpc_709_19","article-title":"The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics","volume":"8","author":"Alesa","year":"2019","journal-title":"J Family Med Prim Care"},{"issue":"5","key":"R49-20230930","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R50-20230930","article-title":"First-generation NSAIDs","author":"Burchum","year":"2019","journal-title":"Lehne's Pharmacology for Nursing Care"},{"issue":"suppl 1","key":"R51-20230930","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20230930","article-title":"Disease-modifying anti-rheumatic drugs (DMARD)","author":"Benjamin","year":"2020"},{"key":"R54-20230930","article-title":"Rheumatoid arthritis","author":"Brucker","year":"2017","journal-title":"Pharmacology for Women's Health"},{"issue":"2","key":"R55-20230930","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40744-017-0073-3","article-title":"Treatment with biologicals in rheumatoid arthritis: an overview","volume":"4","author":"Rein","year":"2017","journal-title":"Rheumatol Ther"},{"issue":"2","key":"R56-20230930","first-page":"1","article-title":"Ahmed I Implementing shared decision making in clinical practice: outcomes of a new shared decision making aid for chronic inflammatory arthritis patients","volume":"2","author":"El Miedany","year":"2016","journal-title":"J Patient Care"},{"issue":"2","key":"R57-20230930","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40744-020-00207-6","article-title":"Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation","volume":"7","author":"Mathew","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"2","key":"R58-20230930","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3899\/jrheum.080147","article-title":"Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change","volume":"36","author":"Schieir","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NURSE.0000718032.41238.db","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T03:12:45Z","timestamp":1696043565000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NURSE.0000718032.41238.db"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.nurse.0000718032.41238.db","relation":{},"ISSN":["0360-4039"],"issn-type":[{"value":"0360-4039","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}